(Total Views: 171)
Posted On: 06/20/2023 2:45:46 PM
Post# of 124781
$MRK News Article - Merck Provides Update on Phase 3 KEYNOTE-585 Trial in Locally Advanced Resectable Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma https://marketwirenews.com/news-releases/merc...77806.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
